Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

WS1 - HCV Biorepository

In this section

The Bio-medical Research Council (BRC), a part of the Oxford Hospital Radcliffe Trust (OHRT), funds research and many of our staff are involved in BRC research.

Our research is funded from a variety of funders. Their support allows our research to focus on the basic and clinical research domains to accelerate knowledge translation from the bedside to the bench, and back again.

doctor writing prescription

vacutainer

 

Work Strand 1 focuses on patient recruitment 

HCV Research UK is instrumental in recruiting patients for study by STOP-HCV. Patients recruited into HCV Research UK will be stratified by viral genotype, treatment history and liver disease status. The objectives of this work strand are to ensure appropriate patient groups are identified for STOP-HCV research studies and to incorporate prospective clinical studies, in particular those using directly acting anti-viral (DAA) drugs, into HCV Research UK.

This Work Strand is led by Dr John McLauchlan (University of Glasgow), coordinator of HCV Research UK.